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Adsorption in hemodialysis. The use of sorbents in different are used to eliminate excess of calcium and to avoid hard
blood purification techniques is reviewed. The sorbents used water syndrome [2]. In medicine, sorbents have been
in these therapies are divided into two groups: (1) Adsorption used to rapidly eliminate both industrial and pharmaco-occurs fundamentally because of the hydrophobic properties
logical exogenous toxins, as well as some endogenousof the sorbents. In this group, the sorbents used in different
toxins such as bilirubin or porphyrines.dialysis techniques are charcoal and nonionic macroporous
resins. (2) Adsorption occurs by chemical affinity, such as ion Sorbents can be divided into large categories: (1) those
exchange resins and chemisorbents. Sorbents were initially that have hydrophobic properties and therefore adsorb
used in hemoperfusion, which caused many adverse events;
the molecules dissolved in the solution in contact with thelater, with the use of coated charcoal, these undesired effects
sorbent, and (2) those that eliminate solutes by chemicaldecreased or disappeared, but the adsorptive properties, water
control, and acid-base balance still created problems. For these affinity [3]. Within the first category, hydrophobic sor-
reasons, the use of sorbents in the treatment of chronic renal bents, there are two subgroups: charcoal and nonionic
failure was almost totally discontinued. Little by little, interest macroporous resin. Charcoal is produced both from bio-in these substances has reappeared, and at present, they have
logical substances such as coconut shells or peach pitsbeen used in combination with other blood purification tech-
and from nonbiological substances, such as petroleum.niques such as hemodialysis, hemofiltration, peritoneal dialysis,
and finally, hemodiafiltration. Within the various hemodiafil- The charcoal is activated by controlled oxidation in air,
tration techniques, paired filtration dialysis-charcoal is being carbon dioxide, or steam. Adsorption into charcoal oc-
used to regenerate the ultrafiltrate, which is used as the replace-
curs through its pores, and therefore, its efficiency de-ment fluid. Charcoal regenerates the ultrafiltrate and trans-
pends on the total number of pores and their radius. Theforms it into a physiological solution with a normal electrolyte
composition, calcium, bicarbonate, and glucose, having elimi- charcoal may be coated or uncoated. Coating charcoal
nated the majority of both middle and large molecule uremic reduces some of its adverse effects, such as platelet en-
toxins. If regeneration is done properly, this replacement fluid trapment, but it also reduces its efficiency, since the diffu-is bacteria and endotoxin free. Studies currently are underway
sion of the toxin from the blood to the charcoal is im-on the adsorption of different inflammatory substances in the
peded by the thickness of the polymer membrane, whichultrafiltrate, which could lead to improvement in the biocom-
patibility of the system. covers it. The nonionic macroporous resins are very simi-
lar to charcoal and are microsphere agglomerates, which
adsorb the toxins they eliminate in their surface. Polysty-
According to the “Consensus Conference on Biocom- rene amberlite is generally used in clinical practice.
patibility,” adsorption is a method for removal of mole- The sorbents, which eliminate substances by chemical
cules from blood or plasma by attachment to a surface affinity, are fundamentally ion exchange resins, which
incorporated in a module within an extracorporeal cir- exchange one ion for another of the same electrical
cuit [1]. Sorbents are substances that, because of their charge. Some substances, which act by chemical links
physical and chemical characteristics, adsorb on their between the sorbent and the solute, are also considered
surface other elements in dissolution. Nephrologists are “chemisorbents.” The ingestion of oxy-starch and oxy-
therefore accustomed to using sorbents in hemodialysis cellulose, for example, eliminates urea and ammonia
units to purify the urban tap water used to produce from the feces.
dialysis fluid. Active carbon—charcoal—is used in the
treatment of this water to adsorb various substances,
SORBENTS AND HEMOPERFUSIONamong which are the chloramines, and also ionic resins
Again, according to the definitions of the “Consensus
Conference on Biocompatibility,” hemoperfusion is theKey words: hemoperfusion, sorbents, biocompatibility, chemisorbents,
macroporous resins, ultrafiltrate. passage of blood across material that adsorbs various
solutes or substances [1]. In nephrology, sorbents wereÓ 2000 by the International Society of Nephrology
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first used by Muirhead and Reid in 1948 [4] and later tory, combined treatments, hemodialysis and hemoper-
by Yatzidis in 1964 [5] in hemoperfusion to eliminate fusion, did not enter routine use.
uremic toxins. However, the adverse effects, principally
platelet depletion, hemolysis, hemorrhage, and hypoten-
SORBENTS AND HEMOFILTRATIONsion, outweighed the advantages. Although the majority
The Redy sorbent cartridge was used by Shaldon etof these adverse effects were solved thanks to the intro-
al to regenerate the hemofiltration ultrafiltrate, using thisduction of coated charcoal by Chang in 1966 [6, 7], the
regenerated liquid for reinfusion [17]. This study wasisolated use of hemoperfusion for the treatment of ure-
discontinued because of the appearance of osteomalaciamia has been discontinued. At present, the use of hemo-
in the patients. Shapiro, Schilb, and Porush also treatedperfusion is an accepted treatment for certain exogenous
four patients for 45 weeks with hemofiltration and regen-intoxication (pharmacological or suicidal). Some recent
eration of the ultrafiltrate by sorbents [18]. He had nostudies implicate a potential benefit derived from sor-
problems with osteomacia and found that blood alumi-bents in the management of acute hepatic failure, cir-
num levels decreased.rhotic ascitis, and septic shock [8–12].
SORBENTS AND HEMODIALYSIS SORBENTS AND CONTINUOUS AMBULATORY
PERITONEAL DIALYSISAfter the failure of hemoperfusion in the treatment
of chronic renal failure, sorbents were used in combina- To increase the number of exchanges without increas-
tion and simultaneously with other dialysis methods. ing dialysis fluid, two authors, Lewin and Maxwell [19]
Gordon et al in 1969 first described a hemodialysis tech- and Roberts et al (abstract; J Am Soc Nephrol 5:426,
nique in which the blood system, including the dialyzer, 1994), reported studies regarding the use of Redy system
was the usual one, but only 6 L of dialysis fluid were used in continuous cyclic peritoneal dialysis. This system re-
in the entire session, as the dialysate was regenerated generated the exchange fluid with sorbents and reused
by sorbents [13]. The cartridge containing the sorbents it. The principal drawback to this system was the de-
consisted of four compartments: the first with urease, crease in the effectiveness of urease caused by the pro-
which transformed urea into ammonia; the second with teins in the peritoneal fluid.
zirconium phosphate, which eliminated ammonia, potas-
sium, calcium, and magnesium; the third compartment,
SORBENTS AND HEMODIAFILTRATIONcontaining hydrated zirconium oxide, which eliminated
Various techniques of hemodiafiltration were devel-phosphates; and the final compartment using charcoal,
oped to reach “adequate dialysis” [20]. But how can wewhich eliminated a large number of both small and mid-
define this term? The word adequate comes from thedle molecules. The system, called “Redy,” had the advan-
Latin term “adecuare,” which means “to equal.” There-tage of not needing running water nor any type of special
fore, adequate dialysis would be that which restores pa-installation and, therefore, could be quickly operated
tients’ parameters to normal; however, the question is,anywhere, for example, intensive care units and catastro-
which parameters? Biochemical, hematological, cardio-phe sites, such as earthquakes. It also had various disad-
vascular? A definition that almost all nephrologists canvantages. The sodium and acid-base balance were diffi-
accept is, “adequate dialysis is the one which restorescult to maintain. Hemodialysis sessions were more
the patients to the most normal length and quality ofexpensive, and in the initial models, the cartridge trans-
life possible, which is tolerated well clinically with aferred aluminum to the dialysis fluid. Therefore, the sys-
minimum of intra- and extra-dialysis problems.” Thistem was used less and less frequently and, at present,
requires not only that the ideal Kt/V must be achieved,does not seem to be in use in hemodialysis units.
but also, considering the existence of small, middle andSorbents have been combined with hemodialysis by
large molecules, the use of more permeable or high-fluxthe inclusion of these substances in the dialyzer mem-
membranes. In addition, proper purification of the widebrane [14]. In this way, the patients’ blood was purified
range of uremic toxins requires maximum diffusion andby diffusion as well as by adsorption on passing through
convection. Finally, biocompatibility must be taken intothe dialyzer. The disadvantage to this method was its
account, given that if we are not sure what the uremicshort efficiency period, as the sorbent became saturated
toxins are, and we therefore do not know precisely whichin the first hour of dialysis and then stopped eliminating
biochemical parameters should be restored to their nor-the uremic toxins.
mal level, “adequate dialysis” at least should not alterOther authors, Stefoni et al [15] and Chang et al [16],
the patient’s status even more. This means that it shouldmodified the dialysis scheme of patients with end-stage
be as biocompatible as possible, since biocompatibilityrenal disease by including a weekly hemoperfusion ses-
sion. Although the reported results were fairly satisfac- is defined as “the ability of a material, device or system
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to perform without a clinically significant host response become difficult. Eight to 10 L of exogenous replacement
fluid must be used. The technology is not simple, as itin a specific application” [21]. Therefore, adequate dial-
ysis should use biocompatible materials, avoid backfil- uses two synchronized pumps to produce the ultrafiltrate
and reinfusion at the same time. For these reasons, atration, and use the purest possible dialysis and reinfu-
sion fluids. regeneration of the ultrafiltrate through sorbents and
its use as replacement fluid were suggested [27]. ThisIn 1978, Leber, Wizemann, and Goubeau described
the technique of hemodiafiltration that through the years technique was originally named PFD-charcoal.
This technique uses the same two chamber dialyzerhas given rise to its different modalities: high-flux hemo-
diafiltration, acetate free hemodiafiltration, etc. [22]. as PFD, but the ultrafiltrate is passed through a charcoal
cartridge and reinfused into the patient’s bloodline inHowever, all of them have at least one drawback: As
diffusion and convection take place simultaneously, both between the two dialyzers. It is important to note that
the production of the ultrafiltrate and infusion of thephenomena interfere with each other and decrease their
respective efficiency. (1) Membrane diffusion decreases replacement fluid can be done with a single pump,
thereby simplifying the process. Different types of coatedthroughout hemodialysis or hemodiafiltration because
of the formation of a pseudo membrane or “protein charcoal (hydrogel acrylic and cellulose) were tried, but
both types of coated charcoal showed deficient adsorp-cake,” which is produced as a consequence of convection
and transmembrane pressure [23]. (2) The following tion of both middle and large molecules. Figure 2 shows
the concentration of b2-microglobulin (b2m) in the ultra-mathematical reasoning explains the decrease in convec-
tive clearance when convection and diffusion coexist si- filtrate after passing through the cartridge throughout
a PFD-charcoal session. However, when the uncoatedmultaneously:
charcoal was used, we could observe that b2m did notClearance of hemodiafiltration: Khdf 5 Kuf 1 Kd appear in the regenerated ultrafiltrate. Therefore, a new
Clearance of ultrafiltration or convection: Kuf 5 Quf (Co/Ci) type of uncoated charcoal was chosen to regenerate the
However, Co , Ci, and therefore Co/Ci , 1.0 ultrafiltrate (BAC MU-AZ; Kureha Chemical Industry
Then, Kuf , Quf Co., Ltd., Tokyo, Japan) [28]. This was possible since
Consequently, [Kd 1 Kuf] , ([Kd] 1 [Kuf]). uncoated charcoal, highly incompatible in direct contact
with blood, could be placed in the ultrafiltrate.where Khdf is the clearance of hemodiafiltration; Kuf is
clearance of ultrafiltration; Kd is clearance of diffusion; Regarding the amount of charcoal to be used in the
cartridges, we observed that 85 g of uncoated charcoalQuf is ultrafiltration flow; Co is concentration out; Ci is
concentration in; [] is one chamber only; ([] 1 []) is one was sufficient to maintain an ultrafiltrate free of small
and middle molecules (creatinine and vitamin B12), butdialyzer with two chambers.
This means that the sum of the two clearances, when the b2m progressively saturated the charcoal. However,
by increasing the amount of charcoal to 130 g, completethese occur simultaneously in the same dialyzer, is less
than the sum of both when they occur in different dia- adsorption of the b2m in the ultrafiltrate occurred
throughout the entire session (Fig. 3). The next steplyzers.
Ghezzi et al first described the paired filtration dialysis was to be sure the electrolytes and glucose were not
adsorbed, thereby making the ultrafiltrate a physiologi-(PFD) technique [24, 25]. In this hemodiafiltration mode,
the hemodialysis filter is composed of two dialyzers in cal fluid, with the proper osmolarity, calcium, bicarbon-
ate, and glucose. Figure 4 shows that the concentrationseries (Fig. 1). The first chamber is a hemofilter for con-
vection only, while the second dialyzer is a made of a low- of bicarbonate and calcium in the regenerated ultrafil-
trate was maintained throughout the session.flux membrane (polysulfone or synthetically modified
cellulose) and is where diffusion occurs. In addition, the Following these in vitro and ex vivo studies, clinical
studies were performed [29, 30]. The multicenter studyultrafiltration necessary to eliminate interdialysis weight
gain occurs in the diffusive dialyzer. Therefore, this tech- by De Francisco et al, which included 33 chronic uremic
patients showed that: (1) there was good clinical toler-nique physically separates convection from diffusion,
thus leading to two main results: (1) the continuous avail- ance; (2) aluminum concentrations in the regenerated
ultrafiltrate were always within the upper limits of AAMIability of pure ultrafiltrate during the whole duration of
the session, and (2) the abrogation of backfiltration of standards; (3) bacteriological studies and measurements
of ultrafiltered endotoxins showed that the regenerateddialyate. The end result is the possibility to regenerate
the ultrafiltrate and to improve the system’s overall bio- ultrafiltrate was bacteria and endotoxin free, thus meet-
ing the pharmacopeia requirements for intravenous in-compatibility. The use, efficiency, and tolerance to this
technique have been proven [26]. However, this tech- jection; (4) patients’ biochemical parameters, as well as
Kt/V and protein catabolic rate, were not significantlynique, as any hemodiafiltration, has various drawbacks:
Buffer and calcium are lost in the ultrafiltrate and, as a altered; (5) the bicarbonate balance improved, and fi-
nally; and (6) there was a significant decrease in serumconsequence, the acid-base balance and the Ca/P balance
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Fig. 1. Schematic drawing of the paired filtration dialysis (PFD) and PFD-charcoal techniques. Abbreviations are: UF, ultrafiltrate; P, pump; R,
reinfusion fluid; D, dialysate; DF, dialysis fluid; and C, charcoal.
Fig. 2. Quantitative ex vivo studies on the removal of b2m (mg/L) from Fig. 3. Quantitative ex vivo studies on the removal of b2m (mg/L) from
ultrafiltrate after passage through charcoal: Effect of coating. b2m was ultrafiltrate after passage through charcoal: Definition of the amount
determined using a highly sensitive radioimmunoassay (Eiken Chemical of charcoal needed for complete removal. Symbols are: (d) coated, 85 g;
Co., Ltd., Tokyo, Japan). Symbols are: (d) coated; (j) uncoated. (j) coated, 130 g.
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this technique, either by diffusion or convection, cannot
explain this decrease. One of the possible explanations
the authors offer for this decrease is that PFD-charcoal
improves biocompatibility, either because there is no
backfiltration or for other reasons. These other reasons
may include the possible existence of proinflammatory
factors (cytokines, complement factors, tumor necrosis
factor-a, interleukin-1, and interleukin-8), which are ad-
sorbed by the charcoal, although it is important to note
that charcoal is not the best sorbent for these inflamma-
tory factors. The use of nonionic macroporous resins is
more efficient [36].
Reprint requests to Julio Botella, M.D., Artesa de Segre, 3-C, 5-B,
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Fig. 4. Bicarbonate (mmol/L; d) and calcium (mg/L; j) concentrations E-mail: jbotella@es.packardbell.org
in the regenerated ultrafiltrate. Concomitant infusion of bicarbonate
and calcium at physiological concentrations could be observed to occur
in the regenerated ultrafiltrate. Bicarbonates and calcium were detected REFERENCES
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